582 related articles for article (PubMed ID: 36879504)
21. Pathogenesis Underlying Neurological Manifestations of Long COVID Syndrome and Potential Therapeutics.
Leng A; Shah M; Ahmad SA; Premraj L; Wildi K; Li Bassi G; Pardo CA; Choi A; Cho SM
Cells; 2023 Mar; 12(5):. PubMed ID: 36899952
[TBL] [Abstract][Full Text] [Related]
22. Neurological post-acute sequelae of SARS-CoV-2 infection.
Takao M; Ohira M
Psychiatry Clin Neurosci; 2023 Feb; 77(2):72-83. PubMed ID: 36148558
[TBL] [Abstract][Full Text] [Related]
23. Infection, Dysbiosis and Inflammation Interplay in the COVID Era in Children.
Ailioaie LM; Ailioaie C; Litscher G
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37446047
[TBL] [Abstract][Full Text] [Related]
24. Prevalence of symptoms, comorbidities, fibrin amyloid microclots and platelet pathology in individuals with Long COVID/Post-Acute Sequelae of COVID-19 (PASC).
Pretorius E; Venter C; Laubscher GJ; Kotze MJ; Oladejo SO; Watson LR; Rajaratnam K; Watson BW; Kell DB
Cardiovasc Diabetol; 2022 Aug; 21(1):148. PubMed ID: 35933347
[TBL] [Abstract][Full Text] [Related]
25. Risk of persistent and new clinical sequelae among adults aged 65 years and older during the post-acute phase of SARS-CoV-2 infection: retrospective cohort study.
Cohen K; Ren S; Heath K; Dasmariñas MC; Jubilo KG; Guo Y; Lipsitch M; Daugherty SE
BMJ; 2022 Feb; 376():e068414. PubMed ID: 35140117
[TBL] [Abstract][Full Text] [Related]
26. Low-dose naltrexone use for the management of post-acute sequelae of COVID-19.
Bonilla H; Tian L; Marconi VC; Shafer R; McComsey GA; Miglis M; Yang P; Bonilla A; Eggert L; Geng LN
Int Immunopharmacol; 2023 Nov; 124(Pt B):110966. PubMed ID: 37804660
[TBL] [Abstract][Full Text] [Related]
27. Long COVID: Molecular Mechanisms and Detection Techniques.
Constantinescu-Bercu A; Lobiuc A; Căliman-Sturdza OA; Oiţă RC; Iavorschi M; Pavăl NE; Șoldănescu I; Dimian M; Covasa M
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203577
[TBL] [Abstract][Full Text] [Related]
28. Role of SARS-CoV-2 Spike-Protein-Induced Activation of Microglia and Mast Cells in the Pathogenesis of Neuro-COVID.
Theoharides TC; Kempuraj D
Cells; 2023 Feb; 12(5):. PubMed ID: 36899824
[TBL] [Abstract][Full Text] [Related]
29. Liquid biomarkers of macrophage dysregulation and circulating spike protein illustrate the biological heterogeneity in patients with post-acute sequelae of COVID-19.
Schultheiß C; Willscher E; Paschold L; Gottschick C; Klee B; Bosurgi L; Dutzmann J; Sedding D; Frese T; Girndt M; Höll JI; Gekle M; Mikolajczyk R; Binder M
J Med Virol; 2023 Jan; 95(1):e28364. PubMed ID: 36458566
[TBL] [Abstract][Full Text] [Related]
30. Humoral SARS-CoV-2 Immune Response in COVID-19 Recovered Vaccinated and Unvaccinated Individuals Related to Post-COVID-Syndrome.
Gerhards C; Kittel M; Ast V; Bugert P; Froelich MF; Hetjens M; Haselmann V; Neumaier M; Thiaucourt M
Viruses; 2023 Feb; 15(2):. PubMed ID: 36851668
[TBL] [Abstract][Full Text] [Related]
31. A Longitudinal Study of COVID-19 Sequelae and Immunity: Baseline Findings.
Sneller MC; Liang CJ; Marques AR; Chung JY; Shanbhag SM; Fontana JR; Raza H; Okeke O; Dewar RL; Higgins BP; Tolstenko K; Kwan RW; Gittens KR; Seamon CA; McCormack G; Shaw JS; Okpali GM; Law M; Trihemasava K; Kennedy BD; Shi V; Justement JS; Buckner CM; Blazkova J; Moir S; Chun TW; Lane HC
Ann Intern Med; 2022 Jul; 175(7):969-979. PubMed ID: 35605238
[TBL] [Abstract][Full Text] [Related]
32. Persistence of SARS CoV-2 S1 Protein in CD16+ Monocytes in Post-Acute Sequelae of COVID-19 (PASC) up to 15 Months Post-Infection.
Patterson BK; Francisco EB; Yogendra R; Long E; Pise A; Rodrigues H; Hall E; Herrera M; Parikh P; Guevara-Coto J; Triche TJ; Scott P; Hekmati S; Maglinte D; Chang X; Mora-Rodríguez RA; Mora J
Front Immunol; 2021; 12():746021. PubMed ID: 35082777
[TBL] [Abstract][Full Text] [Related]
33. Exploring the mechanisms of long COVID: Insights from computational analysis of SARS-CoV-2 gene expression and symptom associations.
Das S; Kumar S
J Med Virol; 2023 Sep; 95(9):e29077. PubMed ID: 37675861
[TBL] [Abstract][Full Text] [Related]
34. Remodeling of T Cell Dynamics During Long COVID Is Dependent on Severity of SARS-CoV-2 Infection.
Wiech M; Chroscicki P; Swatler J; Stepnik D; De Biasi S; Hampel M; Brewinska-Olchowik M; Maliszewska A; Sklinda K; Durlik M; Wierzba W; Cossarizza A; Piwocka K
Front Immunol; 2022; 13():886431. PubMed ID: 35757700
[TBL] [Abstract][Full Text] [Related]
35. Long Covid.
Zaidi AK; Dehgani-Mobaraki P
Prog Mol Biol Transl Sci; 2024; 202():113-125. PubMed ID: 38237983
[TBL] [Abstract][Full Text] [Related]
36. Analysis of post COVID-19 condition and its overlap with myalgic encephalomyelitis/chronic fatigue syndrome.
Sukocheva OA; Maksoud R; Beeraka NM; Madhunapantula SV; Sinelnikov M; Nikolenko VN; Neganova ME; Klochkov SG; Amjad Kamal M; Staines DR; Marshall-Gradisnik S
J Adv Res; 2022 Sep; 40():179-196. PubMed ID: 36100326
[TBL] [Abstract][Full Text] [Related]
37. Postacute COVID-19 is Characterized by Gut Viral Antigen Persistence in Inflammatory Bowel Diseases.
Zollner A; Koch R; Jukic A; Pfister A; Meyer M; Rössler A; Kimpel J; Adolph TE; Tilg H
Gastroenterology; 2022 Aug; 163(2):495-506.e8. PubMed ID: 35508284
[TBL] [Abstract][Full Text] [Related]
38. Persistent SARS-CoV-2 Infection, EBV, HHV-6 and Other Factors May Contribute to Inflammation and Autoimmunity in Long COVID.
Vojdani A; Vojdani E; Saidara E; Maes M
Viruses; 2023 Jan; 15(2):. PubMed ID: 36851614
[TBL] [Abstract][Full Text] [Related]
39. A Review of Respiratory Post-Acute Sequelae of COVID-19 (PASC) and the Potential Benefits of Pulmonary Rehabilitation.
Simon M; Simmons JE
R I Med J (2013); 2022 Sep; 105(7):11-15. PubMed ID: 35930484
[TBL] [Abstract][Full Text] [Related]
40. Longitudinal assessment of anti-SARS-CoV-2 antibody dynamics and clinical features following convalescence from a COVID-19 infection.
Gerhards C; Thiaucourt M; Kittel M; Becker C; Ast V; Hetjens M; Neumaier M; Haselmann V
Int J Infect Dis; 2021 Jun; 107():221-227. PubMed ID: 33932604
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
